v3.26.1
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Assets, Current [Abstract]    
Cash and cash equivalents $ 177,090 $ 33,587
Accounts receivable 5,664 4,435
Inventory 6,949 5,457
Deferred offering costs   935
Other current assets 2,446 1,943
Total current assets 192,149 46,357
Property and equipment, net 2,060 669
Right-of-use assets - operating leases 932 1,068
Other assets 143 55
Total assets 195,284 48,149
Current liabilities    
Accounts payable 2,359 2,223
Operating lease liabilities, current 358 358
Product warranty liability 1,263 844
Accrued payroll, commissions, and bonuses 4,997 4,854
Accrued offering costs 3,500 935
Accrued and other current liabilities 1,995 992
Total current liabilities 14,472 10,206
Warrant liabilities 134 865
Notes payable, net of discount and deferred financing costs 7,279 7,130
Operating lease liabilities, non-current 790 948
Total liabilities 22,675 19,149
Commitments and contingencies (Note 13)
Redeemable convertible preferred issuable in series, stock, $0.01 par value, zero and 67,174,403 shares authorized as of June 30, 2026 and December 31, 2025, respectively; zero and 65,591,701 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; aggregate liquidation value of $0 and 182,255 as of June 30, 2026 and December 31, 2025, respectively   179,773
Stockholders' equity (deficit)    
Common stock, $0.01 par value, 950,000,000 and 86,600,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; 33,286,108 and 884,030 shares outstanding as of June 30, 2026 and December 31, 2025, respectively 333 9
Additional paid-in capital 368,848 7,007
Accumulated deficit (196,572) (157,789)
Total stockholders' equity (deficit) 172,609 (150,773)
Total liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit) $ 195,284 $ 48,149